Skip to Content

FRIDAY, 07 NOVEMBER 2025, 07:15

Science/Tech

Why Yasam Ayavefe’s Mileo Mykonos Leads the Top Ranked Hotels in Mykonos in 2025

Today at 06:43 AM, via Tech Financials

The best hotels on the island are not the ones that try to do everything. They are the ones that decide what matters and do it with care every single day. Mileo Mykonos, shaped by Yasam Ayavefe, has become that kind of address. It sits above Kalo Livadi with a view that never rushes you, […]

Science/Tech

Whales dump $45 billion worth of Bitcoin, entering distribution phase: Why is OPTO Miner’s robust hashrate model more favored?

Today at 06:37 AM, via Tech Financials

The crypto market experienced remarkable volatility in November. According to Bloomberg, long-term Bitcoin holders sold off approximately $45 billion worth of BTC in just two weeks. This figure has made the market realize once again that even the most steadfast “diamond traders” will choose to cash in profits at high levels. Analysts believe this may […]

Science/Tech

Mark Zuckerberg Opened an Illegal School At His Palo Alto Compound. His Neighbor Revolted

Today at 05:30 AM, via Slashdot

Mark Zuckerberg opened an unlicensed school named after the family’s pet chicken — and it was the final straw for his neighbors, writes Slashdot reader joshuark, citing a report from Wired. The magazine obtained 1,665 pages of documents about the neighborhood dispute — “including 311 records, legal filings, construction plans, and emails.” Here are excerpts from the report: The documents reveal...

Health

What Scientists Are Learning From Brain Organoids

Yesterday at 21:00 PM, via New York Times

Lab-grown “reductionist replicas” of the human brain are helping scientists understand fetal development and cognitive disorders, including autism. But ethical questions loom.

Health

Obesity Drugs May Drop to as Little as $150 a Month

Yesterday at 19:06 PM, via New York Times

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.